Report Detail

Request for Sample of this report

Pharma & Healthcare Global OTC Drugs and Dietary Supplement Key Trends and Opportunities to 2027

  • RnM4271560
    • |
  • 02 April, 2021
    • |
  • Global
    • |
  • 204 Pages
    • |
  • QYResearch
    • |
  • Pharma & Healthcare

OTC Drugs and Dietary Supplement market is segmented by companies, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global OTC Drugs and Dietary Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on market size and forecast for the period 2016-2027.
Segment by Type, the OTC Drugs and Dietary Supplement market is segmented into Branded Drugs, Generic Drugs, etc.
Segment by Application, the OTC Drugs and Dietary Supplement market is segmented into Pharmacies/Drugstores, Supermarkets/Hypermarkets, Convenience Stores, Online Drugstores, Health Food Stores, etc.

Regional and Country-level Analysis
The report offers exhaustive assessment of different region-wise and country-wise OTC Drugs and Dietary Supplement markets such as the U.S., Canada, Germany, France, the U.K., Italy, Russia, China, Japan, South Korea, Taiwan, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Argentina, Saudi Arabia, UAE, Turkey, etc.
The report includes country-wise and region-wise market size for the period 2016-2027, by countries (regions), by Type, and by Application, as well as by players for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Competitive Landscape and OTC Drugs and Dietary Supplement Market Share Analysis
OTC Drugs and Dietary Supplement market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2016-2021. Details included are company description, major business, company total revenue and revenue generated in OTC Drugs and Dietary Supplement business, the date to enter into the OTC Drugs and Dietary Supplement market, OTC Drugs and Dietary Supplement product introduction, recent developments, etc.
The major vendors include Abbott Laboratories, ASKA Pharmaceutical Co., Ltd., Fresenius SE & Co KGaA, H. Lundbeck A/S, Lupin Pharmaceuticals, Mylan NV, Nippon Chemiphar Co., Ltd., Novartis AG, Pfizer Inc., Roche Holding, Sanofi SA, Sun Pharmaceutical Industries Ltd, Taisho Pharmaceutical Holdings Co Ltd, Teva Pharmaceuticals, AbbVie, Alexion Pharmaceuticals, Allergan, Amgen, Angelini Group, Astellas Pharma, etc.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global OTC Drugs and Dietary Supplement Market Size by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Branded Drugs
    • 1.2.3 Generic Drugs
  • 1.3 Market by Application
    • 1.3.1 Global OTC Drugs and Dietary Supplement Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Pharmacies/Drugstores
    • 1.3.3 Supermarkets/Hypermarkets
    • 1.3.4 Convenience Stores
    • 1.3.5 Online Drugstores
    • 1.3.6 Health Food Stores
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trend

  • 2.1 Global OTC Drugs and Dietary Supplement Market Perspective (2016-2027)
  • 2.2 Global OTC Drugs and Dietary Supplement Growth Trends by Regions
    • 2.2.1 OTC Drugs and Dietary Supplement Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 OTC Drugs and Dietary Supplement Historic Market Size by Regions (2016-2021)
    • 2.2.3 OTC Drugs and Dietary Supplement Forecasted Market Size by Regions (2022-2027)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 OTC Drugs and Dietary Supplement Industry Trends
    • 2.3.2 OTC Drugs and Dietary Supplement Market Drivers
    • 2.3.3 OTC Drugs and Dietary Supplement Market Challenges
    • 2.3.4 OTC Drugs and Dietary Supplement Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top OTC Drugs and Dietary Supplement Players by Market Size
    • 3.1.1 Players Covered: Ranking by OTC Drugs and Dietary Supplement Revenue
    • 3.1.2 Global Top OTC Drugs and Dietary Supplement Players by Revenue (2016-2021)
    • 3.1.3 Global OTC Drugs and Dietary Supplement Revenue Market Share by Players (2016-2021)
    • 3.1.4 Global OTC Drugs and Dietary Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global OTC Drugs and Dietary Supplement Market Concentration Ratio
    • 3.2.1 Global OTC Drugs and Dietary Supplement Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 5 and Top 10 Players by OTC Drugs and Dietary Supplement Revenue in 2020
  • 3.3 OTC Drugs and Dietary Supplement Key Players Head office and Area Served
  • 3.4 Key Players OTC Drugs and Dietary Supplement Product Solution and Service
  • 3.5 Date of Enter into OTC Drugs and Dietary Supplement Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Global OTC Drugs and Dietary Supplement Breakdown Data by Type (2016-2027)

  • 4.1 Global OTC Drugs and Dietary Supplement Historic Market Size by Type (2016-2021)
  • 4.2 Global OTC Drugs and Dietary Supplement Forecasted Market Size by Type (2022-2027)

5 Global OTC Drugs and Dietary Supplement Breakdown Data by Application (2016-2027)

  • 5.1 Global OTC Drugs and Dietary Supplement Historic Market Size by Application (2016-2021)
  • 5.2 OTC Drugs and Dietary Supplement Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America OTC Drugs and Dietary Supplement Market Size (2016-2027)
  • 6.2 Key OTC Drugs and Dietary Supplement Players Market Share in North America (2020-2021)
  • 6.3 North America OTC Drugs and Dietary Supplement Market Size by Country
    • 6.3.1 North America OTC Drugs and Dietary Supplement Sales by Country (2016-2021)
    • 6.3.2 North America OTC Drugs and Dietary Supplement Market Size Forecast by Country (2022-2027)
  • 6.4 U.S. Market Size Analysis
    • 6.4.1 U.S. OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 6.4.2 U.S. OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 6.4.3 U.S. OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 6.5 Canada Market Size Analysis
    • 6.5.1 Canada OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 6.5.2 Canada OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 6.5.3 Canada OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)

7 Europe

  • 7.1 Europe OTC Drugs and Dietary Supplement Market Size (2016-2027)
  • 7.2 Key OTC Drugs and Dietary Supplement Players Market Share in Europe (2020-2021)
  • 7.3 Europe OTC Drugs and Dietary Supplement Market Size by Country
    • 7.3.1 Europe OTC Drugs and Dietary Supplement Sales by Country (2016-2021)
    • 7.3.2 Europe OTC Drugs and Dietary Supplement Market Size Forecast by Country (2022-2027)
  • 7.4 Germany Market Size Analysis
    • 7.4.1 Germany OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 7.4.2 Germany OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 7.4.3 Germany OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 7.5 France Market Size Analysis
    • 7.5.1 France OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 7.5.2 France OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 7.5.3 France OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 7.6 U.K. Market Size Analysis
    • 7.6.1 U.K. OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 7.6.2 U.K. OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 7.6.3 U.K. OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 7.7 Italy Market Size Analysis
    • 7.7.1 Italy OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 7.7.2 Italy OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 7.7.3 Italy OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 7.8 Russia Market Size Analysis
    • 7.8.1 Russia OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 7.8.2 Russia OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 7.8.3 Russia OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)

8 Asia-Pacific

  • 8.1 Asia-Pacific OTC Drugs and Dietary Supplement Market Size (2016-2027)
  • 8.2 Key OTC Drugs and Dietary Supplement Players Market Share in Asia-Pacific (2020-2021)
  • 8.3 Asia-Pacific OTC Drugs and Dietary Supplement Market Size by Region
    • 8.3.1 Asia-Pacific OTC Drugs and Dietary Supplement Sales by Region (2016-2021)
    • 8.3.2 Asia-Pacific OTC Drugs and Dietary Supplement Market Size Forecast by Region (2022-2027)
  • 8.4 China Market Size Analysis
    • 8.4.1 China OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.4.2 China OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.4.3 China OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.5 Japan Market Size Analysis
    • 8.5.1 Japan OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.5.2 Japan OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.5.3 Japan OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.6 South Korea Market Size Analysis
    • 8.6.1 South Korea OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.6.2 South Korea OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.6.3 South Korea OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.7 India Market Size Analysis
    • 8.7.1 India OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.7.2 India OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.7.3 India OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.8 Australia Market Size Analysis
    • 8.8.1 Australia OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.8.2 Australia OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.8.3 Australia OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.9 Taiwan Market Size Analysis
    • 8.9.1 Taiwan OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.9.2 Taiwan OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.9.3 Taiwan OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.10 Indonesia Market Size Analysis
    • 8.10.1 Indonesia OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.10.2 Indonesia OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.10.3 Indonesia OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.11 Thailand Market Size Analysis
    • 8.11.1 Thailand OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.11.2 Thailand OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.11.3 Thailand OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.12 Malaysia Market Size Analysis
    • 8.12.1 Malaysia OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.12.2 Malaysia OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.12.3 Malaysia OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.13 Philippines Market Size Analysis
    • 8.13.1 Philippines OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.13.2 Philippines OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.13.3 Philippines OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 8.14 Vietnam Market Size Analysis
    • 8.14.1 Vietnam OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 8.14.2 Vietnam OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 8.14.3 Vietnam OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)

9 Latin America

  • 9.1 Latin America OTC Drugs and Dietary Supplement Market Size (2016-2027)
  • 9.2 Key OTC Drugs and Dietary Supplement Players Market Share in Latin America (2020-2021)
  • 9.3 Latin America OTC Drugs and Dietary Supplement Market Size by Country
    • 9.3.1 Latin America OTC Drugs and Dietary Supplement Sales by Country (2016-2021)
    • 9.3.2 Latin America OTC Drugs and Dietary Supplement Market Size Forecast by Country (2022-2027)
  • 9.4 Mexico Market Size Analysis
    • 9.4.1 Mexico OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 9.4.2 Mexico OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 9.4.3 Mexico OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 9.5 Brazil Market Size Analysis
    • 9.5.1 Brazil OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 9.5.2 Brazil OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 9.5.3 Brazil OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 9.6 Argentina Market Size Analysis
    • 9.6.1 Argentina OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 9.6.2 Argentina OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 9.6.3 Argentina OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)

10 Middle East & Africa

  • 10.1 Middle East & Africa OTC Drugs and Dietary Supplement Market Size (2016-2027)
  • 10.2 Key OTC Drugs and Dietary Supplement Players Market Share in Middle East & Africa (2020-2021)
  • 10.3 Middle East & Africa OTC Drugs and Dietary Supplement Market Size by Country
    • 10.3.1 Middle East & Africa OTC Drugs and Dietary Supplement Sales by Country (2016-2021)
    • 10.3.2 Middle East & Africa OTC Drugs and Dietary Supplement Market Size Forecast by Country (2022-2027)
  • 10.4 Turkey Market Size Analysis
    • 10.4.1 Turkey OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 10.4.2 Turkey OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 10.4.3 Turkey OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 10.5 Saudi Arabia Market Size Analysis
    • 10.5.1 Saudi Arabia OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 10.5.2 Saudi Arabia OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 10.5.3 Saudi Arabia OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)
  • 10.6 UAE Market Size Analysis
    • 10.6.1 UAE OTC Drugs and Dietary Supplement Market Size (2016-2027)
    • 10.6.2 UAE OTC Drugs and Dietary Supplement Market Size by Type (2016-2027)
    • 10.6.3 UAE OTC Drugs and Dietary Supplement Market Size by Application (2016-2027)

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview and Its Total Revenue
    • 11.1.3 Abbott Laboratories OTC Drugs and Dietary Supplement Introduction
    • 11.1.4 Abbott Laboratories Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 ASKA Pharmaceutical Co., Ltd.
    • 11.2.1 ASKA Pharmaceutical Co., Ltd. Company Details
    • 11.2.2 ASKA Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
    • 11.2.3 ASKA Pharmaceutical Co., Ltd. OTC Drugs and Dietary Supplement Introduction
    • 11.2.4 ASKA Pharmaceutical Co., Ltd. Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.2.5 ASKA Pharmaceutical Co., Ltd. Recent Development
  • 11.3 Fresenius SE & Co KGaA
    • 11.3.1 Fresenius SE & Co KGaA Company Details
    • 11.3.2 Fresenius SE & Co KGaA Business Overview and Its Total Revenue
    • 11.3.3 Fresenius SE & Co KGaA OTC Drugs and Dietary Supplement Introduction
    • 11.3.4 Fresenius SE & Co KGaA Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.3.5 Fresenius SE & Co KGaA Recent Development
  • 11.4 H. Lundbeck A/S
    • 11.4.1 H. Lundbeck A/S Company Details
    • 11.4.2 H. Lundbeck A/S Business Overview and Its Total Revenue
    • 11.4.3 H. Lundbeck A/S OTC Drugs and Dietary Supplement Introduction
    • 11.4.4 H. Lundbeck A/S Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.4.5 H. Lundbeck A/S Recent Development
  • 11.5 Lupin Pharmaceuticals
    • 11.5.1 Lupin Pharmaceuticals Company Details
    • 11.5.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
    • 11.5.3 Lupin Pharmaceuticals OTC Drugs and Dietary Supplement Introduction
    • 11.5.4 Lupin Pharmaceuticals Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.5.5 Lupin Pharmaceuticals Recent Development
  • 11.6 Mylan NV
    • 11.6.1 Mylan NV Company Details
    • 11.6.2 Mylan NV Business Overview and Its Total Revenue
    • 11.6.3 Mylan NV OTC Drugs and Dietary Supplement Introduction
    • 11.6.4 Mylan NV Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.6.5 Mylan NV Recent Development
  • 11.7 Nippon Chemiphar Co., Ltd.
    • 11.7.1 Nippon Chemiphar Co., Ltd. Company Details
    • 11.7.2 Nippon Chemiphar Co., Ltd. Business Overview and Its Total Revenue
    • 11.7.3 Nippon Chemiphar Co., Ltd. OTC Drugs and Dietary Supplement Introduction
    • 11.7.4 Nippon Chemiphar Co., Ltd. Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.7.5 Nippon Chemiphar Co., Ltd. Recent Development
  • 11.8 Novartis AG
    • 11.8.1 Novartis AG Company Details
    • 11.8.2 Novartis AG Business Overview and Its Total Revenue
    • 11.8.3 Novartis AG OTC Drugs and Dietary Supplement Introduction
    • 11.8.4 Novartis AG Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.8.5 Novartis AG Recent Development
  • 11.9 Pfizer Inc.
    • 11.9.1 Pfizer Inc. Company Details
    • 11.9.2 Pfizer Inc. Business Overview and Its Total Revenue
    • 11.9.3 Pfizer Inc. OTC Drugs and Dietary Supplement Introduction
    • 11.9.4 Pfizer Inc. Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.9.5 Pfizer Inc. Recent Development
  • 11.10 Roche Holding
    • 11.10.1 Roche Holding Company Details
    • 11.10.2 Roche Holding Business Overview and Its Total Revenue
    • 11.10.3 Roche Holding OTC Drugs and Dietary Supplement Introduction
    • 11.10.4 Roche Holding Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.10.5 Roche Holding Recent Development
  • 11.11 Sanofi SA
    • 11.11.1 Sanofi SA Company Details
    • 11.11.2 Sanofi SA Business Overview and Its Total Revenue
    • 11.11.3 Sanofi SA OTC Drugs and Dietary Supplement Introduction
    • 11.11.4 Sanofi SA Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.11.5 Sanofi SA Recent Development
  • 11.12 Sun Pharmaceutical Industries Ltd
    • 11.12.1 Sun Pharmaceutical Industries Ltd Company Details
    • 11.12.2 Sun Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
    • 11.12.3 Sun Pharmaceutical Industries Ltd OTC Drugs and Dietary Supplement Introduction
    • 11.12.4 Sun Pharmaceutical Industries Ltd Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.12.5 Sun Pharmaceutical Industries Ltd Recent Development
  • 11.13 Taisho Pharmaceutical Holdings Co Ltd
    • 11.13.1 Taisho Pharmaceutical Holdings Co Ltd Company Details
    • 11.13.2 Taisho Pharmaceutical Holdings Co Ltd Business Overview and Its Total Revenue
    • 11.13.3 Taisho Pharmaceutical Holdings Co Ltd OTC Drugs and Dietary Supplement Introduction
    • 11.13.4 Taisho Pharmaceutical Holdings Co Ltd Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.13.5 Taisho Pharmaceutical Holdings Co Ltd Recent Development
  • 11.14 Teva Pharmaceuticals
    • 11.14.1 Teva Pharmaceuticals Company Details
    • 11.14.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
    • 11.14.3 Teva Pharmaceuticals OTC Drugs and Dietary Supplement Introduction
    • 11.14.4 Teva Pharmaceuticals Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.14.5 Teva Pharmaceuticals Recent Development
  • 11.15 AbbVie
    • 11.15.1 AbbVie Company Details
    • 11.15.2 AbbVie Business Overview and Its Total Revenue
    • 11.15.3 AbbVie OTC Drugs and Dietary Supplement Introduction
    • 11.15.4 AbbVie Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.15.5 AbbVie Recent Development
  • 11.16 Alexion Pharmaceuticals
    • 11.16.1 Alexion Pharmaceuticals Company Details
    • 11.16.2 Alexion Pharmaceuticals Business Overview and Its Total Revenue
    • 11.16.3 Alexion Pharmaceuticals OTC Drugs and Dietary Supplement Introduction
    • 11.16.4 Alexion Pharmaceuticals Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.16.5 Alexion Pharmaceuticals Recent Development
  • 11.17 Allergan
    • 11.17.1 Allergan Company Details
    • 11.17.2 Allergan Business Overview and Its Total Revenue
    • 11.17.3 Allergan OTC Drugs and Dietary Supplement Introduction
    • 11.17.4 Allergan Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.17.5 Allergan Recent Development
  • 11.18 Amgen
    • 11.18.1 Amgen Company Details
    • 11.18.2 Amgen Business Overview and Its Total Revenue
    • 11.18.3 Amgen OTC Drugs and Dietary Supplement Introduction
    • 11.18.4 Amgen Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.18.5 Amgen Recent Development
  • 11.19 Angelini Group
    • 11.19.1 Angelini Group Company Details
    • 11.19.2 Angelini Group Business Overview and Its Total Revenue
    • 11.19.3 Angelini Group OTC Drugs and Dietary Supplement Introduction
    • 11.19.4 Angelini Group Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.19.5 Angelini Group Recent Development
  • 11.20 Astellas Pharma
    • 11.20.1 Astellas Pharma Company Details
    • 11.20.2 Astellas Pharma Business Overview and Its Total Revenue
    • 11.20.3 Astellas Pharma OTC Drugs and Dietary Supplement Introduction
    • 11.20.4 Astellas Pharma Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.20.5 Astellas Pharma Recent Development
  • 11.21 AstraZeneca
    • 11.21.1 AstraZeneca Company Details
    • 11.21.2 AstraZeneca Business Overview and Its Total Revenue
    • 11.21.3 AstraZeneca OTC Drugs and Dietary Supplement Introduction
    • 11.21.4 AstraZeneca Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.21.5 AstraZeneca Recent Development
  • 11.22 Bausch Health
    • 11.22.1 Bausch Health Company Details
    • 11.22.2 Bausch Health Business Overview and Its Total Revenue
    • 11.22.3 Bausch Health OTC Drugs and Dietary Supplement Introduction
    • 11.22.4 Bausch Health Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.22.5 Bausch Health Recent Development
  • 11.23 Beacons Pharmaceuticals（Pte) Ltd.
    • 11.23.1 Beacons Pharmaceuticals（Pte) Ltd. Company Details
    • 11.23.2 Beacons Pharmaceuticals（Pte) Ltd. Business Overview and Its Total Revenue
    • 11.23.3 Beacons Pharmaceuticals（Pte) Ltd. OTC Drugs and Dietary Supplement Introduction
    • 11.23.4 Beacons Pharmaceuticals（Pte) Ltd. Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.23.5 Beacons Pharmaceuticals（Pte) Ltd. Recent Development
  • 11.24 BeiGene
    • 11.24.1 BeiGene Company Details
    • 11.24.2 BeiGene Business Overview and Its Total Revenue
    • 11.24.3 BeiGene OTC Drugs and Dietary Supplement Introduction
    • 11.24.4 BeiGene Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.24.5 BeiGene Recent Development
  • 11.25 Biogen
    • 11.25.1 Biogen Company Details
    • 11.25.2 Biogen Business Overview and Its Total Revenue
    • 11.25.3 Biogen OTC Drugs and Dietary Supplement Introduction
    • 11.25.4 Biogen Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.25.5 Biogen Recent Development
  • 11.26 Boehringer Ingelheim
    • 11.26.1 Boehringer Ingelheim Company Details
    • 11.26.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 11.26.3 Boehringer Ingelheim OTC Drugs and Dietary Supplement Introduction
    • 11.26.4 Boehringer Ingelheim Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.26.5 Boehringer Ingelheim Recent Development
  • 11.27 Bristol-Myers Squibb
    • 11.27.1 Bristol-Myers Squibb Company Details
    • 11.27.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 11.27.3 Bristol-Myers Squibb OTC Drugs and Dietary Supplement Introduction
    • 11.27.4 Bristol-Myers Squibb Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.27.5 Bristol-Myers Squibb Recent Development
  • 11.28 Yunnan Baiyao Group Co., Ltd
    • 11.28.1 Yunnan Baiyao Group Co., Ltd Company Details
    • 11.28.2 Yunnan Baiyao Group Co., Ltd Business Overview and Its Total Revenue
    • 11.28.3 Yunnan Baiyao Group Co., Ltd OTC Drugs and Dietary Supplement Introduction
    • 11.28.4 Yunnan Baiyao Group Co., Ltd Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.28.5 Yunnan Baiyao Group Co., Ltd Recent Development
  • 11.29 Dabur India Limited
    • 11.29.1 Dabur India Limited Company Details
    • 11.29.2 Dabur India Limited Business Overview and Its Total Revenue
    • 11.29.3 Dabur India Limited OTC Drugs and Dietary Supplement Introduction
    • 11.29.4 Dabur India Limited Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.29.5 Dabur India Limited Recent Development
  • 11.30 Harbin Pharmaceutical Group
    • 11.30.1 Harbin Pharmaceutical Group Company Details
    • 11.30.2 Harbin Pharmaceutical Group Business Overview and Its Total Revenue
    • 11.30.3 Harbin Pharmaceutical Group OTC Drugs and Dietary Supplement Introduction
    • 11.30.4 Harbin Pharmaceutical Group Revenue in OTC Drugs and Dietary Supplement Business (2016-2021)
    • 11.30.5 Harbin Pharmaceutical Group Recent Development

12 Analyst's Viewpoints/Conclusion

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source

    Summary:
    Get latest Market Research Reports on OTC Drugs and Dietary Supplement. Industry analysis & Market Report on OTC Drugs and Dietary Supplement is a syndicated market report, published as Global OTC Drugs and Dietary Supplement Key Trends and Opportunities to 2027. It is complete Research Study and Industry Analysis of OTC Drugs and Dietary Supplement market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$6,600.00
    		$9,900.00
    		$13,200.00
    		5,280.00
    		7,920.00
    		10,560.00
    		6,164.40
    		9,246.60
    		12,328.80
    		1,042,404.00
    		1,563,606.00
    		2,084,808.00
    		550,638.00
    		825,957.00
    		1,101,276.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo